The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Tag: Neutrophil
Engineered nanovesicles from activated neutrophils show promise in treating infected wounds
A recent study has developed nanovesicles (NVs) from activated neutrophils, showcasing their ability to perform molecular debridement and accelerate healing in infectious wounds. This novel method significantly enhances treatment effectiveness, particularly for stubborn diabetic wounds, by targeting and neutralizing deep tissue pathogens.
Researchers Uncover Mechanisms behind Enigmatic Shapes of Nuclei
White blood cells known as neutrophils feature a nucleus that is structured strikingly different than most nuclei. These unique shapes permit neutrophils to travel all over the body to combat invading pathogens.
How a Lowly Immune Cell Helps the Immune System Fight Cancer
New research reveals that long-underestimated neutrophils play key role in determining success of cancer immunotherapy
Research Group Identifies Potential Therapeutic Target for Lupus
Inhibiting IRE1α, a molecule activated by the endoplasmic reticulum in neutrophils, counters disease progression in lupus mice.
New Cause of COVID-19 Blood Clots Identified
A new study reveals that COVID-19 triggers production of antibodies circulating through the blood, causing clots in people hospitalized with the disease.
Higher Levels of NETs in Blood Associated with More Severe COVID-19
New study explores the connection between levels of a type of destructive white blood cell, known as a neutrophil, with the severity of COVID-19.